The proliferation of fraudulent clinical research has reached epidemic proportions, creating a major headache for practitioners. There were roughly 10,000 fraudulent papers retracted by medical journals last year, the highest number on record. While the problem affects all areas of medicine, the field of nutrition is especially vulnerable (Image: PeopleImages–Yuri A/Shutterstock)
Good
medical practice is based on trust.
Patients trust that practitioners are knowledgeable, and that they use their knowledge intheir patients’ best interests. In turn, practitioners trust that researchers run their studies honestly, and that editors and peer-reviewers of the medical journals carefully scrutinize the papers they receive, sift out the garbage, and only publish studies that pass clinical, statistical, and ethical muster.
Research itself is also a trust proposition. From the lead investigators who design trials, and the Institutional Review Boards (IRBs) that approve them, to the research assistants and post-doctoral fellows who crunch the data, and the authors who write and submit the papers, there’s a thread of trust that depends on the right people doing the right things at each point along the path.
Written by Jonathan Jones, PhD, Contributing Writer
Hibiscus sabdariffa (hibiscus) and Lippia citriodora (lemon verbena) are two polyphenol-rich botanicals that, when combined, can act synergistically to regulate blood pressure. Oxidative stress, a key factor in the development and progression of hypertension, can lead to vascular damage and atherosclerosis. Mitigating oxidative stress is, therefore, an important aspect of managing hypertension. Natural polyphenols, like […]
The Food and Drug Administration has issued new rules aimed at bolstering the agency’s oversight and regulation of the diagnostic testing field. Specifically, the FDA is taking aim at Laboratory-Developed Tests (LDTs), which are defined as in vitro medical tests designed, manufactured, and processed by a single clinical laboratory. Historically, LDTs were unique, highly targeted […]
Risk assessment is a foundation of good clinical
practice. Accurate and individualized risk prediction allows for informed
decision-making, enhanced disease screening and personalized risk-reduction
strategies for your patients.
We’re all aware of the use of penetrant genes
like BRCA1/2 as genomic markers for cancer susceptibility. But there is
a lesser-known disease susceptibility indicator known as polygenic risk
score (PRS), that can be highly valuable in clinical practice.
In this FREE webinar, Dr. Joel Evans will
explore the role of PRS in clinical decision-making. He’ll highlight the value
of PRS when integrated with other clinical risk factors in assessing a patient’s
risk of developing disease, and describe how to implement this type of
clinically-integrated genetic technology in longevity-focused precision
medicine practice.
As a
women’s healthcare practitioner with a passion for hormone replacement therapy,
Dr. Evans will focus specifically on the benefits of PRS for breast cancer risk
assessment. He’ll also touch on application of the same technology for other
cancers including ovarian, colorectal, pancreatic, prostate and melanoma, and
other common disorders like type 2 diabetes and heart disease.
With PRS assessment, you can now offer your patients the latest in disease risk
prediction to create personalized treatment plans to increase health span,
wellness, and longevity.
You’ll learn:
The
basics of predictive genomics in the context of polygenic risk
How
assessment of polygenic risk, in combination with other clinical risk factors, can
positively impact your implementation of longevity medicine
Practical
approaches for utilizing the latest in genomic-integrated clinical risk
prediction into your clinical practice
Joel Evans, MD, is Chief Medical Officer at geneType, and is a board-certified OB/GYN and international lecturer. He is the Director of The Center for Functional Medicine in Ridgefield, CT, and Chief of Medical Affairs for the Institute for Functional Medicine. Dr. Evans is renowned for his passion for mind-body medicine. His special interest in breast cancer led him to serve as the Medical Director of the Keep A Breast Foundation. Dr. Evans brings decades of applied research about cancer risk and prevention to his patients, and to the functional medicine community.
